Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Epidemiol Infect ; 144(1): 171-81, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26041509

ABSTRACT

Between December 2010 and July 2011, 252 cases of STEC O157 PT8 stx1 + 2 infection were reported in England, Scotland and Wales. This was the largest outbreak of STEC reported in England and the second largest in the UK to date. Eighty cases were hospitalized, with two cases of haemolytic uraemic syndrome and one death reported. Routine investigative data were used to generate a hypothesis but the subsequent case-control study was inconclusive. A second, more detailed, hypothesis generation exercise identified consumption or handling of vegetables as a potential mode of transmission. A second case-control study demonstrated that cases were more likely than controls to live in households whose members handled or prepared leeks bought unwrapped [odds ratio (OR) 40, 95% confidence interval (CI) 2·08-769·4], and potatoes bought in sacks (OR 13·13, 95% CI 1·19-145·3). This appears to be the first outbreak of STEC O157 infection linked to the handling of leeks.


Subject(s)
Disease Outbreaks , Escherichia coli Infections/epidemiology , Escherichia coli O157/genetics , Food Microbiology , Onions/microbiology , Solanum tuberosum/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Child , Child, Preschool , Electrophoresis, Gel, Pulsed-Field , England/epidemiology , Escherichia coli Infections/complications , Escherichia coli Infections/microbiology , Escherichia coli Infections/mortality , Escherichia coli O157/isolation & purification , Female , Hemolytic-Uremic Syndrome/epidemiology , Hemolytic-Uremic Syndrome/etiology , Hemolytic-Uremic Syndrome/microbiology , Humans , Infant , Infant, Newborn , Male , Middle Aged , Minisatellite Repeats , Multilocus Sequence Typing , Scotland/epidemiology , Wales/epidemiology , Young Adult
2.
Pathol Biol (Paris) ; 63(3): 136-43, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25845294

ABSTRACT

Hemolytic uremic syndrome is a rare disease, frequently responsible for renal insufficiency in children. Recent findings have led to renewed interest in this pathology. The discovery of new gene mutations in the atypical form of HUS and the experimental data suggesting the involvement of the complement pathway in the typical form, open new perspectives for treatment. This review summarizes the current state of knowledge on both typical and atypical hemolytic uremic syndrome pathophysiology and examines new perspectives for treatment.


Subject(s)
Hemolytic-Uremic Syndrome/physiopathology , Animals , Anti-Bacterial Agents/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Bacterial Infections/complications , Bacterial Toxins/adverse effects , Clinical Trials as Topic , Complement System Proteins/physiology , Disease Models, Animal , Drug Evaluation, Preclinical , Escherichia coli Infections/complications , Escherichia coli Infections/microbiology , Forecasting , Genetic Predisposition to Disease , Hemolytic-Uremic Syndrome/classification , Hemolytic-Uremic Syndrome/etiology , Hemolytic-Uremic Syndrome/genetics , Hemolytic-Uremic Syndrome/microbiology , Hemolytic-Uremic Syndrome/therapy , Humans , Kidney Transplantation , Liver Transplantation , Mice , Papio , Plasma , Plasma Substitutes , Shiga Toxin/adverse effects , Shiga-Toxigenic Escherichia coli/immunology , Shiga-Toxigenic Escherichia coli/pathogenicity , Thrombophilia/etiology , Vascular Endothelial Growth Factor A/therapeutic use
3.
Nephrol Dial Transplant ; 29(7): 1369-76, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24744281

ABSTRACT

BACKGROUND: Acute kidney injury (AKI) has increasingly been recognized as an important public health issue due to its rising frequency, its associations with early and late adverse outcomes and its economic burden. METHODS: Given the importance of determining the available resources to address this serious issue, the AKI Committee of SLANH conducted a survey to obtain information about infrastructure, human resources and equipment devoted to the treatment of AKI in Latin America RESULTS: A total of 246 units from 14 countries participated in the survey, the majority of them pertaining to nephrology divisions in teaching hospitals. Intermittent hemodialysis was universally performed by all of the units, and less frequently, slow extended dialysis (40%) and continuous renal replacement therapy (23%) were performed. Seventy-nine units (30%) perform peritoneal dialysis, but only 51 (19%) of them reported having treated at least 1 patient with this technique in the last 3 months pre-survey. The vast majority of the units reported adequate water treatment and use of modern filter membranes. Most of the patients received renal replacement therapy (RRT) in the intensive care unit. Specific causes of AKI were reported in different frequencies, with a heterogeneous pattern among the countries. Septic abortion, hemolytic-uremic syndrome, community-acquired diarrhea and leptospirosis were the etiologies most frequently associated with AKI. CONCLUSIONS: To our knowledge, this report was the first available study of the equipment and human resources utilized for RRT in AKI patients in Latin America.


Subject(s)
Acute Kidney Injury/therapy , Health Resources/trends , Renal Replacement Therapy/methods , Acute Kidney Injury/complications , Diarrhea/diagnosis , Diarrhea/etiology , Hemolytic-Uremic Syndrome/diagnosis , Hemolytic-Uremic Syndrome/etiology , Humans , International Agencies , Latin America , Leptospirosis/diagnosis , Leptospirosis/etiology , Renal Dialysis/methods , Renal Replacement Therapy/adverse effects
4.
Biochem Cell Biol ; 84(2): 157-66, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16609696

ABSTRACT

Shiga toxin (Stx) produced by enterohemorrhagic Escherichia coli is a critical factor in the onset of hemolytic uremic syndrome. The current study was designed to assess whether n-3 and (or) n-6 polyunsaturated fatty acids (PUFA) act as a valuable adjunct to prevent the cell injury of renal tubule cells in the emergence of HUS. The target cells, ACHN cells derived from human tubule epithelium, were cultured with each PUFA, then exposed to Stx-1 or Stx-2. The rank order of potency of PUFA to inhibit the cell death caused by each toxin was as follows: EPA > AA = DHA >> LNA. There were dose-response relations in the efficacy of each PUFA. No prophylactic effect was found in the cultures with LA. Immunofluorescence assays revealed that both the expression of the toxin receptor on ACHN cells and binding between the toxin and cells were unaffected by the PUFA. These results suggest that EPA is the most efficacious PUFA against the renal tubule cell injury caused by Stx, which may be assigned to an alteration in the intracellular pathway leading to cell death.


Subject(s)
Fatty Acids, Unsaturated/pharmacology , Kidney Tubules/drug effects , Shiga Toxin/antagonists & inhibitors , Shiga Toxin/toxicity , Cell Line , Cell Survival/drug effects , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , Escherichia coli/pathogenicity , Fatty Acids, Omega-3/pharmacology , Fatty Acids, Omega-6/pharmacology , Fatty Acids, Unsaturated/administration & dosage , Hemolytic-Uremic Syndrome/etiology , Hemolytic-Uremic Syndrome/prevention & control , Humans , Kidney Tubules/metabolism , Kidney Tubules/pathology , Receptors, Cell Surface/metabolism , Shiga Toxin/metabolism , Shiga Toxin 1/toxicity , Shiga Toxin 2/toxicity , Trihexosylceramides/metabolism
5.
Pediatr Med Chir ; 17(1): 69-71, 1995.
Article in Italian | MEDLINE | ID: mdl-7739932

ABSTRACT

Many pathogenetic factors may enhance coagulation process and induce thrombosis. The Authors report a case of hemolytic-uremic syndrome, with marked evidence of macroscopic kidney thrombotic involvement, in which an important dyslipidemia (hypertriglyceridemia and hypercholesterolemia) was detected during the phase of clinical improvement. These findings, and the contemporary marked reduction of fibrinolytic activity, seem to be relevant pathogenetic factors in this case. The treatment with polyunsaturated fatty acids Omega 3 may have been helpful in modifying these serum abnormalities and maybe could have brought to the clinical improvement.


Subject(s)
Blood Coagulation Disorders/complications , Hemolytic-Uremic Syndrome/etiology , Hypercholesterolemia/complications , Hypertriglyceridemia/complications , Blood Coagulation Tests , Child, Preschool , Fatty Acids, Omega-3/therapeutic use , Female , Hemolytic-Uremic Syndrome/diagnosis , Humans , Hypercholesterolemia/drug therapy , Hypertriglyceridemia/drug therapy , Kidney/diagnostic imaging , Thrombosis/complications , Thrombosis/diagnostic imaging , Tomography, X-Ray Computed
6.
Vet Rec ; 122(10): 240, 1988 Mar 05.
Article in English | MEDLINE | ID: mdl-3363822
SELECTION OF CITATIONS
SEARCH DETAIL